NASDAQ:CBIO | Free Cash Flow | CRESCENT BIOPHARMA, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.94M$147,000.00-$9.08M
2025-12-31-$26.74M$193,000.00-$26.93M
2025-03-31-$10.85M$0.00-$10.85M
2024-12-31-$3.7M$0.00-$3.7M
2024-03-31-$10.51M$7,439.00-$10.52M
2023-12-31-$7.61M$801.00-$7.62M
2023-03-31-$11.61M$2,197.00-$11.61M
2022-12-31-$7.91M$1.00-$7.91M
2022-03-31-$13.7M$40,521.00-$13.74M
2021-12-31-$12.81M$2,447.00-$12.81M
2021-03-31-$14.13M$3,060.00-$14.13M
2020-12-31-$9.69M$38,175.00-$9.72M
2020-03-31-$3.5M$8,136.00-$3.51M
2019-12-31-$12.79M$12,357.00-$12.81M
2019-03-31-$14.35M$39,538.00-$14.39M
2018-12-31-$9.98M$57,004.00-$10.04M
2018-03-31-$10.21M$16,618.00-$10.23M
2017-12-31-$8.37M$34,247.00-$8.4M
2017-03-31-$9.06M$62,969.00-$9.12M
2016-12-31-$5.95M$438,567.00-$6.39M
2016-03-31-$9.23M$17,270.00-$9.25M
2015-12-31-$6.96M$3,227.00-$6.96M
2015-03-31-$8.71M$2,339.00-$8.71M
2014-12-31-$6.15M$14,865.00-$6.17M
2014-03-31-$2.59M$13,920.00-$2.6M
2013-12-31-$5.57M$12,430.00-$5.58M
2013-03-31-$3.88M$6,824.00-$3.88M-844.78%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$71.53M$919,000.00-$72.45M
2024-12-31-$31.1M$9,972.00-$31.11M
2023-12-31-$34.88M$21,394.00-$34.9M
2022-12-31-$46.46M$84,191.00-$46.54M
2021-12-31-$57.49M$14,943.00-$57.5M
2020-12-31-$39.24M$68,507.00-$39.31M
2019-12-31-$51.98M$144,928.00-$52.13M
2018-12-31-$43.33M$125,618.00-$43.46M
2017-12-31-$29.77M$294,107.00-$30.06M
2016-12-31-$29.73M$704,202.00-$30.44M
2015-12-31-$8.24M$268,594.00-$8.51M
2014-12-31-$4.28M$212,603.00-$4.49M
2013-12-31-$15.54M$82,091.00-$15.62M
2012-12-31-$10.47M$316,180.00-$10.79M-295.12%